Error in Figure 1 - Takeaways - MDSpire

Correction to Figure 1 in the PANORAMA Trial Report on Intravitreal Aflibercept for Severe Nonproliferative Diabetic Retinopathy

Share

1

The PANORAMA trial report evaluated intravitreal aflibercept for severe nonproliferative diabetic retinopathy.
2

The report underwent an online correction after its initial posting on August 5, 2021.
3

The correction addressed numerical inconsistencies in Figure 1.
4

The correction clarified a time point in the Results section.
5

The correction fixed a typographical error in eTable 3 of Supplement 2, and the article appeared in the September issue.